Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Prognostic Value of Interim PET/CT in Predicting Outcomes of Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP Therapy: A Retrospective Analysis from Single Centre, Riyadh, Saudi Arabia

Asim A Alharbi, Abdullah Alsakkaf, Abdullah M. Alrajhi, Tahani Alhalouly, Bilal Albtoosh, Kamal Alzahrani, Mohammed S Alnoamani, Hassan Alshehri, Nawal F Alshehry, Ibraheem H Motabi, Mohammed Marei, Muhned Alhumaid, Imran K Tailor

Blood (2024) 144 (Supplement 1): 6439.

https://doi.org/10.1182/blood-2024-208523

Published: 2024

Journal Articles

Outcomes of Post-Transplant Cyclophosphamide Prophylaxis in Matched Sibling Donor Allogeneic Hematopoietic Cell Transplant: A Retrospective Study at a Single Tertiary Center in Saudi Arabia

Alaa Eldein Yahia, Abdullah Alsakkaf, Faisal Abdullah Alshehri, Zahra AlHaj Issa, Aws A. Alsuhaibani, Jude Howaidi, Abdullah M. Alrajhi, Bilal Albtoosh, Gamal Mohamed, Ammar Hasan Alsughayir, Mohammed S Alnoamani, Kamal Alzahrani, Nawal F Alshehry, Imran K Tailor, Mohammed Marei, Ibraheem H Motabi, Muhned Alhumaid, Hassan Alshehri

Blood (2024) 144 (Supplement 1): 7316.

https://doi.org/10.1182/blood-2024-206866

Published: 2024

Journal Articles

Effectiveness of Nivolumab with ICE Protocol in Relapsed or Refractory Hodgkin Lymphoma: A Single-Center Experience from Riyadh, Saudi Arabia

Abdullah Alsakkaf, Alaa Eldein Yahia, Asim A Alharbi, Abdullah M. Alrajhi, Tahani Alhalouly, Bilal Albtoosh, Kamal Alzahrani, Mohammed S Alnoamani, Muhned Alhumaid, Hassan Alshehri, Nawal F Alshehry, Ibraheem H Motabi, Mohammed Marei, Imran K Tailor

Blood (2024) 144 (Supplement 1): 6376.

https://doi.org/10.1182/blood-2024-204017

Published: 2024

Journal Articles

Bleomycin Induced Lung Toxicity in Hodgkin Lymphoma Patients Treated with ABVD Regimen- a Single Center Experience from Riyadh, Saudi Arabia

Alaa Eldein Yahia, Abdullah Alsakkaf, Hassan Alshehri, Nawal F Alshehry, Abdullah M. Alrajhi, Bilal Albtoosh, Tahani Alhalouly, Mohammed S Alnoamani, Muhned Alhumaid, Kamal Alzahrani, Mohammed Marei, Ibraheem H Motabi, Imran K Tailor

Blood (2024) 144 (Supplement 1): 6374.

https://doi.org/10.1182/blood-2024-203962

Published: 2024

Journal Articles

Bv-AVD Esclation after Partial Response to ABVD Chemotherapy in Patinets with HL: A Retrospective Study

Amani Almuqbil, Abdullah Alrajhi, Hassan Alshehri, Ibraheem H Motabi, Imran K Tailor, Kamal Alzahrani, Mohammed Marei, Mohammed S Alnoamani, Nawal F Alshehry, Muhned Alhumaid

Blood (2024) 144 (Supplement 1): 6373.

https://doi.org/10.1182/blood-2024-203089

Published: 2024

Journal Articles

Outcomes of Secondary CNS Lymphoma with Carmustine/Thiotepa Conditioning and Autologous Stem Cell Transplant-a Case Series from Single Center, Saudi Arabia

Zakarya Bahaliwah, Alaa Eldein Yahia, Abdullah Alsakkaf, Tahani Alhalouly, Kamal Alzahrani, Ammar Hasan Alsughayir, Mohammed S Alnoamani, Hassan Alshehri, Nawal F Alshehry, Muhned Alhumaid, Mohammed Marei, Ibraheem H Motabi, Imran K Tailor

Blood (2024) 144 (Supplement 1): 6446.

https://doi.org/10.1182/blood-2024-204789

Published: 2024

Journal Articles

Efficacy and Safety of AALL0232 Protocol in Adults with Acute Lymphoblastic Leukemia: Single Institution Experience

Abdullah M. Alrajhi, Mashael Alrouqi, Jude Howaidi, Mohammmad Alwadi, Hassan Alshehri, Imran K Tailor, Mohammed S Alnoamani, Nawal F Alshehry, Ibraheem H Motabi, Mohammed A Marei, Muhned Alhumaid

Blood (2023) 142 (Supplement 1): 7367.

https://doi.org/10.1182/blood-2023-189082

Published: 2023

Journal Articles

Blinatumomab with Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

Blood (2023) 142 (Supplement 1): 5889.

https://doi.org/10.1182/blood-2023-180221

Published: 2023

Journal Articles

Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study

Mohammmad Alwadi, Jude Howaidi, Abdullah M Alrajhi, Adel Alnakhli, Mohammed A. Marei, Imran K. Tailor, Fouad H. Alnajjar, Syed Y. Altaf, Mohammed S. Alnoamani, Kamal Alzahrani, Hassan Alshehri, Ibraheem H. Motabi, Syed Ziauddin A Zaidi, Nawal F Alshehry, Mansour Alfayez

Blood (2021) 138 (Supplement 1): 4423.

https://doi.org/10.1182/blood-2021-153335

Published: 2021

Journal Articles

JAK2 GGCC (46/1) Haplotype in Unprovoked Venous Thrombotic Events

Maged Al-Ammari, Abdul Ali Peer Zada, Ibraheem H. Motabi, Belal M. Albtoosh, Syed Y. Altaf, Imran K. Tailor, Mohammed S. Alnoamani, Syed Ziauddin A Zaidi, Mansour Alfayez, Nawal F Alshehry, Mohammed A. Marei

Blood (2021) 138 (Supplement 1): 4258.

https://doi.org/10.1182/blood-2021-149560

Published: 2021

Journal Articles

Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital

Abdullah M Alrajhi, Razan A. Aljalali, Lara H. Alghazi, Ibrahim Asiri, Adel Alnakhli, Fouad H. Alnajjar, Nawal F Alshehry, Ibraheem H. Motabi, Mohammed S. Alnoamani, Mohammed A. Marei, Mansour Alfayez, Imran K. Tailor

Blood (2021) 138 (Supplement 1): 4532.

https://doi.org/10.1182/blood-2021-152911

Published: 2021

Journal Articles

Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience

Marwa Bin Morya, Mohammed A. Marei, Imran K. Tailor, Abdullah M Alrajhi, Adel Alnakhli, Foud Alnajjar, Mohammed S. Alnoamani, Hassan Alshehri, Ibraheem H. Motabi, Nawal AlShehry, Mansour Alfayez

Blood (2021) 138 (Supplement 1): 4558.

https://doi.org/10.1182/blood-2021-150242

Published: 2021

Journal Articles

Outcomes of GCSF and Pre-Emptive Plerixafor Based Peripheral Blood Stem Cell Mobilization Among Patients with Multiple Myeloma-Experience from Newly Established Transplant Unit in Eastern Mediterranean Area

Imran K Tailor, MBBS, MD FRCP, FRCPath, Nawal AlShehry, Nurah F Alenezi, Belal Albtoosh, BSc, RN, Ammar H. Alsughayir, MD, Mohammed Marei, MD, Syed Y Altaf, MD, Syed Ziauddin A Zaidi, FRCP,FRCPath,MBBS, Imran A Pukhta, MD, Rabab Alhazeem, RN, Mansour Alfayez, MDMS, Ibraheem Motabi

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-140677

Published: 2020

Journal Articles

Excellent Outcomes of Patients of Middle Eastern Ethnic Origin with Autologous Haemopoietic Stem Cell Transplantation and COVID-19: Does a Dampened Immune System Protect Against Severe COVID-19?

Imran K Tailor, MBBS, MD FRCP, FRCPath, Syed Y Altaf, MD, Nawal F Alshehry, MD, Alaa M Alser, MDMRCP, Mohammed Marei, MD, Mansour Alfayez, MDMS, Ibraheem Motabi, Syed Ziauddin A Zaidi, FRCP,FRCPath,MBBS

Blood (2020) 136 (Supplement 1): 3.

https://doi.org/10.1182/blood-2020-140682

Published: 2020

Journal Articles

Outcomes of Patients of Eastern Mediterranean Region with Lymphoma and COVID-19.Does Recent Chemo Immunotherapy Have a Role on Severity?

Imran K Tailor, MBBS, MD FRCP, FRCPath, Nawal F Alshehry, MD, Kamran Sabir, FCPS, Abdul Rehman Z Zaidi, MBBS, Mohammed Marei, MD, Ibraheem Motabi, Mansour Alfayez, MDMS, Syed Ziauddin A Zaidi, FRCP,FRCPath,MBBS, Syed Y Altaf, MD

Blood (2020) 136 (Supplement 1): 25.

https://doi.org/10.1182/blood-2020-140685

Published: 2020

Journal Articles

Very High Seroprevalence of CMV and EBV Among a Large Series of Patients with Hematological Malignancies at a Tertiary Care Center in Saudi Arabia - a Case for Investigating Cooperativity of Viruses in Carcinogenesis?

Abdul Rehman Z. Zaidi, MBBS, Maged O. Al-Ammari, MBBS, MD, Mohammed AlNoamani, MBBS, Syed Y. Altaf, MD, Nawal AlShehry, MD, Imran K. Tailor, MD, Ibraheem H. Motabi, MD, Mubarak S. AlGhamdi, MD, Syed Ziauddin A. Zaidi, FRCP,FRCPath,MBBS

Blood (2019) 134 (Supplement_1): 5818.

https://doi.org/10.1182/blood-2019-131323

Published: 2019

Journal Articles

Doublet Versus Triplet PET: Is END of Therapy PET Needed IF Interim PET Is Negative in Hodgkin'S or Diffuse Large B CELL Lymphoma?

Imran K Tailor, MBBS, MD FRCP, FRCPath, Bilal Btoosh, RN, Shaimaa Hamdy, MD, Shanker Raja, MD, Mohammed O Alharbi, Ibraheem H Motabi, MRCP MD, Nawal Faiez Alshehry, MD SBIM, SBAH, Mohammed S Qureshi, FCPS, Mubarak S. AlGhamdi, MD, Syed Ziauddin A. Zaidi, MBBS, FRCP, FCPS, FRCPath, FACP

Blood (2016) 128 (22): 5354.

https://doi.org/10.1182/blood.V128.22.5354.5354

Published: 2016

Journal Articles

Primary Central Nervous System Lymphoma Treatment Outcomes-a Decade's Experience from a Single Centre in Riyadh, Saudi Arabia

Imran K Tailor, MBBS, MD FRCP, FRCPath, Taimoor Hussain, MBBS FCPS, Wafa Shakweer, Ibraheem H Motabi, MRCP MD, Ghulam Murtaza, MBBS, FCPS, Syed Ziauddin A. Zaidi, MBBS, FRCP, FRCPath, FACP, Nawal F Shehry, Mubarak S. AlGhamdi, MD, Yasser Bayoumi, MD, Samer Mudaibigh, MD SBIM, SBAH

Blood (2016) 128 (22): 5416.

https://doi.org/10.1182/blood.V128.22.5416.5416

Published: 2016

Journal Articles

Secondary Central Nervous System Involvement with Concurrent Diffuse Large B Cell Lymphoma at Initial Presentation or at Relapse Is Associated with Zero Survival- a Decade's Experience from a Single Centre in Riyadh, Saudi Arabia

Imran K Tailor, MBBS, MD FRCP, FRCPath, Taimoor Hussain, MBBS FCPS, Wafa Shakweer, Ghulam Murtaza, MBBS, FCPS, Ibraheem H Motabi, MRCP MD, Syed Ziauddin A. Zaidi, MBBS, FRCP, FCPS, FRCPath, FACP, Nawal F Shehry, Yasser Bayoumi, MD, Mubarak S. AlGhamdi, MD

Blood (2016) 128 (22): 5417.

https://doi.org/10.1182/blood.V128.22.5417.5417

Published: 2016

Journal Articles

Report of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in Four Patients with Hematological Malignancies Treated at King Fahad Medical City, Riyadh, Saudi Arabia

Ibraheem H Motabi, MRCP MD, Syed Ziauddin A. Zaidi, MBBS, FRCP, FCPS, FRCPath, FACP, Mamoun Hassan Ibrahim, MBBS, MRCPI, SBAH, Imran K Tailor, MBBS, MD FRCP, FRCPath, Nawal Faiez Alshehry, MD SBIM, SBAH, Mubarak S. AlGhamdi, MD, Shahid Iqbal, MBBS, FCPS, MRCP, Samer Mudaibigh, MD SBIM, SBAH, Fouad H Alnajjar, PharmD, MSc, BCOP

Blood (2016) 128 (22): 4903.

https://doi.org/10.1182/blood.V128.22.4903.4903

Published: 2016

NARROW

Prognostic Value of Interim PET/CT in Predicting Outcomes of Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP Therapy: A Retrospective Analysis from Single Centre, Riyadh, Saudi Arabia

Outcomes of Post-Transplant Cyclophosphamide Prophylaxis in Matched Sibling Donor Allogeneic Hematopoietic Cell Transplant: A Retrospective Study at a Single Tertiary Center in Saudi Arabia

Effectiveness of Nivolumab with ICE Protocol in Relapsed or Refractory Hodgkin Lymphoma: A Single-Center Experience from Riyadh, Saudi Arabia

Bleomycin Induced Lung Toxicity in Hodgkin Lymphoma Patients Treated with ABVD Regimen- a Single Center Experience from Riyadh, Saudi Arabia

Bv-AVD Esclation after Partial Response to ABVD Chemotherapy in Patinets with HL: A Retrospective Study

Outcomes of Secondary CNS Lymphoma with Carmustine/Thiotepa Conditioning and Autologous Stem Cell Transplant-a Case Series from Single Center, Saudi Arabia

Efficacy and Safety of AALL0232 Protocol in Adults with Acute Lymphoblastic Leukemia: Single Institution Experience

Blinatumomab with Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study

JAK2 GGCC (46/1) Haplotype in Unprovoked Venous Thrombotic Events

Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital

Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience

Outcomes of GCSF and Pre-Emptive Plerixafor Based Peripheral Blood Stem Cell Mobilization Among Patients with Multiple Myeloma-Experience from Newly Established Transplant Unit in Eastern Mediterranean Area

Excellent Outcomes of Patients of Middle Eastern Ethnic Origin with Autologous Haemopoietic Stem Cell Transplantation and COVID-19: Does a Dampened Immune System Protect Against Severe COVID-19?

Outcomes of Patients of Eastern Mediterranean Region with Lymphoma and COVID-19.Does Recent Chemo Immunotherapy Have a Role on Severity?

Very High Seroprevalence of CMV and EBV Among a Large Series of Patients with Hematological Malignancies at a Tertiary Care Center in Saudi Arabia - a Case for Investigating Cooperativity of Viruses in Carcinogenesis?

Doublet Versus Triplet PET: Is END of Therapy PET Needed IF Interim PET Is Negative in Hodgkin'S or Diffuse Large B CELL Lymphoma?

Primary Central Nervous System Lymphoma Treatment Outcomes-a Decade's Experience from a Single Centre in Riyadh, Saudi Arabia

Secondary Central Nervous System Involvement with Concurrent Diffuse Large B Cell Lymphoma at Initial Presentation or at Relapse Is Associated with Zero Survival- a Decade's Experience from a Single Centre in Riyadh, Saudi Arabia

Report of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in Four Patients with Hematological Malignancies Treated at King Fahad Medical City, Riyadh, Saudi Arabia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only